- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Dr. Nancy E Kemeny
Dr. Nancy E. Kemeny is a leading medical oncologist practicing in the state of New York. She is an expert in new chemotherapy treatments for liver cancer, but also works with other cancers, including peritoneal carcinomas like mesothelioma. Dr. Kemeny has been a staff member at Memorial Sloan-Kettering Cancer Center for over 30 years. As a researcher, she has been involved in the development and studies of many drugs that are currently in use for treating these cancers.
Dr. Nancy E. Kemeny is board-certified in internal medicine and in medical oncology. Her residency was completed at St. Luke’s Hospital in NYC. Her fellowship was conducted at the prestigious cancer hospital Memorial Sloan-Kettering. In addition to her work at the hospital, Dr. Kemeny is a Professor of Medicine at Weill Medical College, Cornell University.
The doctor is well respected for her research and knowledge about cancer and chemotherapy. She led a large group study to assist the FDA with its approval of a colorectal cancer treatment drug, Oxilaplatin. An important area of her expertise is with regional cancer drug therapy, in which the treatment medication is delivered directly to the tumor, especially in the case of liver cancer.
Dr. Kemeny works exclusively at Memorial Sloan-Kettering Cancer Center, one of the nation's top rated hospitals. She received her M.D. from the University of Medicine and Dentistry of New Jersey. Her specialty is internal medicine, with particular dedication to the research and study of chemotherapy and colorectal cancers.
Memorial Sloan-Kettering Cancer Center is a National Cancer Institute)-designated Comprehensive Cancer Center. Only 40 hospitals in the country are qualified to receive this designation from NCI. These hospitals are the best for treating cancer and provide the most support, research and medical expertise for that purpose.
Dr. Nancy E. Kemeny is a frequently published author on her specialties and research. She has written 61 medical publications. She is highly respected as an expert leader in her area of medicine. As a member of many professional organizations, she is active on numerous committees that focus on cancer drugs and other oncology issues. Dr. Kemeny is frequently invited to speak at professional organization meetings. She serves on the boards of three medical journals and is a scientific reviewer for many others.
Dr. Kemeny has also conducted studies that involve multi-modal therapies, including both regional and systemic chemotherapy, for treating various cancers. Her breakthrough research in the delivery system of drugs directly to inoperable liver tumors has resulted in making those cancers suitable for surgery in many patients.